Related Experiment Video
Updated: Sep 12, 2025
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Patients With Inflammatory Bowel Disease Are at Increased Risk of Interstitial Lung Diseases
Bharati Kochar1,2,3, Jiangwei Sun4, Ola Olén5,6
1Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Introduction:
Pulmonary manifestations have been postulated in inflammatory bowel disease (IBD), but supporting data are scarce. We examined the risk of interstitial lung diseases (ILD) in IBD and its subtypes (ulcerative colitis, Crohn's disease, and IBD-unclassified).
Methods:
We conducted a nationwide cohort study of individuals diagnosed with IBD in Sweden between 1969 and 2019 and followed until 2021. For each patient, we identified up to 5 matched general-population comparators. Through Cox regression, we examined adjusted hazard ratios for ILD as defined by diagnostic codes in the National Patient Register. In a secondary analysis, patients with IBD were compared with their siblings free of IBD.
Results:
We identified 85,705 patients with IBD and 412,677 general-population comparators. Over a median follow-up of 14 years, 438 patients (0.51%) with IBD and 1,253 comparators (0.30%) were diagnosed with ILD, corresponding to incidence rates of 34 and 20 per 100,000 person-years, respectively. Patients with IBD had a 48% greater relative risk of ILD (95% confidence interval 1.30-1.69). Stratified analyses showed increased risk in both ulcerative colitis and Crohn's disease. Patients with IBD also had a significantly greater risk of developing ILD compared with their siblings (adjusted hazard ratio 1.81, 95% confidence interval 1.43-2.27).
Discussion:
In this nationwide cohort study of >85,000 patients with incident IBD, we found an increased risk of ILD.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids